Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Novartis Picks Merkley Unit For Incontinence Drug

Merkley Newman Harty & Partners Healthworks is in final negotiations to take on creative duties for Enablex, an incontinence drug from Novartis Pharmaceuticals, sources said. The unit of Omnicom’s Merkley Newman Harty & Partners in New York was selected after a review that also included sibling shop BBDO Health, said sources. Billings have not been determined, but sources estimated spending to be $30 million. Merkley could not be reached, and the East Hanover, N.J.,

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in